JP2005513034A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513034A5
JP2005513034A5 JP2003547374A JP2003547374A JP2005513034A5 JP 2005513034 A5 JP2005513034 A5 JP 2005513034A5 JP 2003547374 A JP2003547374 A JP 2003547374A JP 2003547374 A JP2003547374 A JP 2003547374A JP 2005513034 A5 JP2005513034 A5 JP 2005513034A5
Authority
JP
Japan
Prior art keywords
compound
formula
overproduction
iii
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003547374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005513034A (ja
Filing date
Publication date
Priority claimed from GBGB0128376.1A external-priority patent/GB0128376D0/en
Application filed filed Critical
Publication of JP2005513034A publication Critical patent/JP2005513034A/ja
Publication of JP2005513034A5 publication Critical patent/JP2005513034A5/ja
Pending legal-status Critical Current

Links

JP2003547374A 2001-11-27 2002-11-25 スルホン誘導体ならびに自己免疫疾患およびアレルギーの治療におけるその使用 Pending JP2005513034A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0128376.1A GB0128376D0 (en) 2001-11-27 2001-11-27 Novel compounds
PCT/EP2002/013263 WO2003045922A1 (en) 2001-11-27 2002-11-25 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies

Publications (2)

Publication Number Publication Date
JP2005513034A JP2005513034A (ja) 2005-05-12
JP2005513034A5 true JP2005513034A5 (enExample) 2006-01-05

Family

ID=9926523

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003547374A Pending JP2005513034A (ja) 2001-11-27 2002-11-25 スルホン誘導体ならびに自己免疫疾患およびアレルギーの治療におけるその使用

Country Status (11)

Country Link
US (1) US7038055B2 (enExample)
EP (1) EP1448529B1 (enExample)
JP (1) JP2005513034A (enExample)
AR (1) AR037426A1 (enExample)
AT (1) ATE299497T1 (enExample)
AU (1) AU2002365510A1 (enExample)
DE (1) DE60205035T2 (enExample)
ES (1) ES2243783T3 (enExample)
GB (1) GB0128376D0 (enExample)
TW (1) TW200303746A (enExample)
WO (1) WO2003045922A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706255D0 (en) * 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
BR9810760A (pt) 1997-07-31 2001-11-27 Abbott Lab Inibidores de hidroxamato reverso demetaloproteinases de matriz
CN100402496C (zh) 1998-01-30 2008-07-16 达尔文发现有限公司 用作基质金属蛋白酶抑制剂的化合物
CZ20023853A3 (cs) * 2000-05-25 2003-05-14 Smithkline Beecham P. L. C. Bicyklyl- nebo heterobicyklylmethansulfonylaminosubstituované N-hydroxyformamidy

Similar Documents

Publication Publication Date Title
JP2005500357A5 (enExample)
JP2004534850A5 (enExample)
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
JP2003503454A5 (enExample)
JP2007514005A5 (enExample)
JP2005537234A5 (enExample)
JP2009502743A5 (enExample)
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
EP2573079A3 (en) Benzimidazole quinolinones and uses thereof
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
JP2002510633A5 (enExample)
WO2003009838A1 (en) Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
JP2003522198A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2006514116A5 (enExample)
JP2005513036A5 (enExample)
JP2008513510A5 (enExample)
JP2005509503A5 (enExample)
JP2003528919A5 (enExample)
CA2632207C (en) Use of calcitonin for the treatment of ra
JP2004538314A5 (enExample)
JP2006508124A5 (enExample)
JP2002537256A5 (enExample)
JP2002522462A5 (enExample)
JP2005513034A5 (enExample)